Protara Therapeutics Statistics Share Statistics Protara Therapeutics has 38.58M
shares outstanding. The number of shares has increased by 87.02%
in one year.
Shares Outstanding 38.58M Shares Change (YoY) 87.02% Shares Change (QoQ) 4.93% Owned by Institutions (%) 68.68% Shares Floating 35.46M Failed to Deliver (FTD) Shares 11,247 FTD / Avg. Volume 2.96%
Short Selling Information The latest short interest is 2.69M, so 6.98% of the outstanding
shares have been sold short.
Short Interest 2.69M Short % of Shares Out 6.98% Short % of Float 7.15% Short Ratio (days to cover) 18.47
Valuation Ratios The PE ratio is -2.44 and the forward
PE ratio is -2.57.
Protara Therapeutics's PEG ratio is
0.06.
PE Ratio -2.44 Forward PE -2.57 PS Ratio 0 Forward PS 7.4 PB Ratio 0.65 P/FCF Ratio -3.03 PEG Ratio 0.06
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Protara Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 15.71,
with a Debt / Equity ratio of 0.03.
Current Ratio 15.71 Quick Ratio 15.71 Debt / Equity 0.03 Debt / EBITDA -0.09 Debt / FCF -0.12 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.59M Employee Count 28 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 124.87% in the
last 52 weeks. The beta is 1.51, so Protara Therapeutics's
price volatility has been higher than the market average.
Beta 1.51 52-Week Price Change 124.87% 50-Day Moving Average 3.25 200-Day Moving Average 3.85 Relative Strength Index (RSI) 76.04 Average Volume (20 Days) 380,141
Income Statement
Revenue n/a Gross Profit -332K Operating Income -49.15M Net Income -44.6M EBITDA -49.15M EBIT -40.42M Earnings Per Share (EPS) -2.17
Full Income Statement Balance Sheet The company has 162.8M in cash and 4.48M in
debt, giving a net cash position of 158.31M.
Cash & Cash Equivalents 162.8M Total Debt 4.48M Net Cash 158.31M Retained Earnings -244.98M Total Assets 156.93M Working Capital 115.33M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -35.81M
and capital expenditures -63K, giving a free cash flow of -35.87M.
Operating Cash Flow -35.81M Capital Expenditures -63K Free Cash Flow -35.87M FCF Per Share -1.74
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields TARA does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for TARA is $21,
which is 394.1% higher than the current price. The consensus rating is "Buy".
Price Target $21 Price Target Difference 394.1% Analyst Consensus Buy Analyst Count 5
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jan 10, 2020. It was a
backward
split with a ratio of 1:40.
Last Split Date Jan 10, 2020 Split Type backward Split Ratio 1:40
Scores Altman Z-Score 3.91 Piotroski F-Score 1
